Cargando…
Current Developments in the Use of Biomarkers for Juvenile Idiopathic Arthritis
Use of biomarkers in clinical practice has proved extremely valuable and is a rapidly expanding field. However, despite the huge potential of biomarkers, for juvenile idiopathic arthritis (JIA) there are currently no validated paediatric biomarkers available to help with setting up a more tailored a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930839/ https://www.ncbi.nlm.nih.gov/pubmed/24445961 http://dx.doi.org/10.1007/s11926-013-0406-3 |